Share your research, clinical insights, and innovative approaches to multiple sclerosis care at the CMSC 2027 Annual Meeting in San Diego, California, June 2–4, 2027.
Abstract Submissions Open
October 1, 2026
Abstract Submission Deadline
January 15, 2027
Acceptance Notification
February 28, 2027
Late-Breaking Abstract Submissions Open
February 1, 2027
Late-Breaking Abstract Submission Deadline
April 15, 2027
Attendance Confirmation Deadline
May 15, 2027
Poster Upload Deadline
May 15, 2027
Platform Presentation Upload Deadline
May 24, 2027
All dates are subject to change. Please check back for updates.
CMSC Abstracts — Now Open
Submit original research, clinical findings, and innovative approaches related to multiple sclerosis care, including diagnosis, treatment, rehabilitation, symptom management, and other aspects of comprehensive MS care.
Case Studies/Series — Now Open
Submit clinical cases or case series that provide valuable insights into MS diagnosis, management, treatment decisions, or unusual clinical presentations.
Whitaker Abstracts — Now Open
A special opportunity for young professionals to showcase their research and contributions to multiple sclerosis care.
View the Whitaker Abstract submission guidelines and requirements on the dedicated Whitaker page.
Late-Breaking Abstracts — Opening February 1, 2027
Reserved for significant new scientific research or clinical findings that were not available before the regular abstract submission deadline.
All accepted late-breaking abstracts will be presented as posters. Additional eligibility requirements and submission instructions will be available when submissions open.
All healthcare professionals are welcome to submit abstracts. CMSC membership or sponsorship by a member is not required.
Abstract Formatting Requirements
Abstract body: Maximum 2,500 characters, including spaces.
Abstract title: Maximum 150 characters, using appropriate capitalization.
Authors are responsible for proofreading their abstracts for correct grammar and spelling.
Previously presented or published abstracts (encore presentations) are accepted.
Abstracts will be evaluated based on the quality of the work and the appropriateness of the topic.
Author Disclosures
All authors must provide their disclosures.
Industry Participation
Platform Presentations: Work from commercial-interest authors and presenters may be considered if the content focuses on basic science rather than products or commercial aspects. Acceptance is determined by the CMSC Abstract Review Committee in consultation with the CMSC CE Committee.
Poster Presentations: Industry-employed authors may submit work if employed in scientific or medical divisions. Authors working in industry sales or marketing are not eligible for inclusion in the scientific poster session. This applies to individual authors and co-authors.
Number of Submissions
CMSC does not limit the number of submissions per first author. However, CMSC strongly recommends that individuals present no more than two posters.
Platform Presentations
Presenters selected for platform presentations must be available at their assigned presentation time. Each presentation should not exceed 15 minutes, followed by 5 minutes for questions and answers.
Due to limited availability, some abstracts submitted for platform consideration may be assigned to a poster session.
Platform sessions will offer continuing education credit.
Poster Presentations
Presenters are responsible for preparing, transporting, and displaying their posters, including any required materials and supplies.
Poster boards measure 4 feet high × 8 feet wide.
Presenters must be available during their assigned poster session to discuss their work with attendees.
Presentation schedules, poster setup times, and assigned sessions will be announced at a later date.
Commitment to Present
Submitting an abstract indicates a commitment to present the work at the CMSC Annual Meeting if accepted.
Conference Registration
Authors of accepted abstracts must register for the conference.
Travel and Registration Expenses
CMSC cannot provide direct assistance with presentation-related expenses.
Scholarship support may be available through a separate application process. Scholarship applications are independent of abstract review and acceptance.
To ensure a balanced and unbiased platform for information, employees of commercial entities will NOT be permitted to serve as speakers for platform presentations.
This policy is designed to prioritize academic integrity and foster an environment where knowledge and ideas can be shared without commercial influence.
Thank you for your understanding and cooperation.
In support of improving patient care, the Consortium of Multiple Sclerosis Centers (CMSC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CMSC is committed to complying with the rules and guidelines established by these agencies to ensure that accreditation standards are strictly followed.
The work of commercial-interest authors and presenters will be considered for review provided that the content focuses on basic science rather than a product or the commercial aspects of a discovery.
Acceptance of an abstract for a platform presentation depends solely on the decision of the CMSC Abstract Review Committee in consultation with the CMSC CE Committee.
Authors of poster submissions should present information about studies or projects that benefit the multiple sclerosis scientific and/or clinical community.
Work submitted by authors employed in the pharmaceutical or other healthcare industries will be considered, provided the authors work within scientific and/or medical divisions.
Authors employed in industry sales or marketing positions are not eligible for inclusion in the scientific poster session.
This policy applies to poster submissions, whether submitted individually or in a co-authoring capacity.
The CMSC Abstract Review Committee will review all abstracts. Submissions will be evaluated for clarity, relevance to MS, originality, scientific merit, and for the purpose of resolution of any identified conflict of interest (COI) on the part of the author(s). Submissions will be evaluated on an equal basis, whether theme-related or of general interest, although preference will be given to data-based submissions for platform presentations.
Notification: Notifications for CMSC regular submissions will be sent out via email no later than February 28, 2027.
Registration: All Platform and Poster presenters must register for the meeting and will be required to cover all costs related to their annual meeting attendance.
All accepted abstracts will be published in the International Journal of MS Care (IJMSC) for distribution during the CMSC Annual Meeting. Accepted abstracts will also be made available on the CMSC Annual Meeting website.
About the Journal
The International Journal of MS Care is a peer-reviewed journal dedicated to multidisciplinary multiple sclerosis care.
Visit the journal’s website at www.ijmsc.org.
Author Responsibilities
Authors are responsible for reviewing their abstract information carefully and submitting any necessary corrections or updates in a timely manner.
All requested changes must be submitted by the established deadline.
Changes After the Deadline
CMSC and the International Journal of MS Care reserve the right to reject requests for corrections, revisions, or other changes received after the designated deadline.
The CMSC recognizes outstanding abstracts through several awards celebrating excellence in multiple sclerosis research, clinical care, and education.
CMSC Research Award
Presented to the best Platform presentation and the best Poster presentation featuring innovative research in multiple sclerosis.
Patient and Family Education Award
Presented to the best Platform presentation and the best Poster presentation focused on patient and family education in multiple sclerosis.
Award Selection and Recognition
Abstract reviewers may recommend submissions for award consideration.
Recipients of the CMSC Research Award and Patient and Family Education Award will receive a plaque and complimentary registration to a subsequent CMSC Annual Meeting for the first author only.
Additional Awards and Recognition
Other awards and special recognitions will also be presented during the CMSC Annual Meeting to acknowledge outstanding contributions to the multiple sclerosis community.
Questions about abstract content, submission rules, guidelines, or acceptance notifications?
Jennifer Pichardo
(201) 487-1050 ext. 115
Need assistance with the abstract submission system?
Confex Support
+1 401-334-0220
Email: Daily, 7 AM–11 PM ET
Phone: Mon–Fri, 8 AM–6 PM ET